Gemma L. Nixon

1.6k total citations
21 papers, 625 citations indexed

About

Gemma L. Nixon is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Gemma L. Nixon has authored 21 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Public Health, Environmental and Occupational Health, 8 papers in Infectious Diseases and 8 papers in Organic Chemistry. Recurrent topics in Gemma L. Nixon's work include Malaria Research and Control (14 papers), Computational Drug Discovery Methods (5 papers) and Synthesis and Catalytic Reactions (4 papers). Gemma L. Nixon is often cited by papers focused on Malaria Research and Control (14 papers), Computational Drug Discovery Methods (5 papers) and Synthesis and Catalytic Reactions (4 papers). Gemma L. Nixon collaborates with scholars based in United Kingdom, United States and Switzerland. Gemma L. Nixon's co-authors include Paul M. O’Neill, Stephen A. Ward, Giancarlo A. Biagini, Alison E. Shone, Nicholas Fisher, David G. Lalloo, W. David Hong, Darren Moss, Richard K. Amewu and Jill Davies and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Gemma L. Nixon

20 papers receiving 619 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gemma L. Nixon United Kingdom 13 290 216 173 133 131 21 625
Alison E. Shone United Kingdom 10 348 1.2× 208 1.0× 164 0.9× 97 0.7× 149 1.1× 11 579
Rita Capela Portugal 13 260 0.9× 230 1.1× 169 1.0× 106 0.8× 79 0.6× 18 597
Mathew Njoroge South Africa 17 207 0.7× 319 1.5× 222 1.3× 129 1.0× 134 1.0× 43 688
Edwin O. Nuzum United States 9 327 1.1× 271 1.3× 200 1.2× 142 1.1× 103 0.8× 10 755
Frans J. Smit South Africa 16 172 0.6× 289 1.3× 164 0.9× 75 0.6× 85 0.6× 21 478
Tina Mutka United States 14 246 0.8× 243 1.1× 209 1.2× 63 0.5× 100 0.8× 21 648
W. Armand Guiguemde United States 14 252 0.9× 228 1.1× 167 1.0× 64 0.5× 121 0.9× 18 533
José M. Fiandor Spain 12 175 0.6× 284 1.3× 242 1.4× 84 0.6× 85 0.6× 23 555
Richard M. Beteck South Africa 13 132 0.5× 319 1.5× 252 1.5× 95 0.7× 70 0.5× 49 616
Rozalia A. Dodean United States 14 231 0.8× 211 1.0× 185 1.1× 100 0.8× 64 0.5× 20 621

Countries citing papers authored by Gemma L. Nixon

Since Specialization
Citations

This map shows the geographic impact of Gemma L. Nixon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gemma L. Nixon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gemma L. Nixon more than expected).

Fields of papers citing papers by Gemma L. Nixon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gemma L. Nixon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gemma L. Nixon. The network helps show where Gemma L. Nixon may publish in the future.

Co-authorship network of co-authors of Gemma L. Nixon

This figure shows the co-authorship network connecting the top 25 collaborators of Gemma L. Nixon. A scholar is included among the top collaborators of Gemma L. Nixon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gemma L. Nixon. Gemma L. Nixon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nixon, Gemma L., et al.. (2024). Symmetrical Phosphinic Acids: Synthesis and Esterification Optimization toward Potential HIV Prodrugs. ACS Omega. 9(40). 41742–41757.
2.
Du, Min, Andrew J. Carnell, Roger Barraclough, et al.. (2023). Targeted Destruction of S100A4 Inhibits Metastasis of Triple Negative Breast Cancer Cells. Biomolecules. 13(7). 1099–1099. 12 indexed citations
3.
Nixon, Gemma L., Neil G. Berry, Suet C. Leung, et al.. (2023). Design, synthesis and modelling of photoreactive chemical probes for investigating target engagement of plasmepsin IX and X in Plasmodium falciparum. RSC Chemical Biology. 5(1). 19–29. 6 indexed citations
4.
Berry, Neil G., Gemma L. Nixon, Suet C. Leung, et al.. (2021). Development of Pyrazolopyrimidine Anti-Wolbachia Agents for the Treatment of Filariasis. ACS Medicinal Chemistry Letters. 12(9). 1421–1426. 6 indexed citations
5.
Nixon, Gemma L., Nicoletta Basilico, Silvia Parapini, et al.. (2021). Enantioselective Synthesis and Profiling of Potent, Nonlinear Analogues of Antimalarial Tetraoxanes E209 and N205. ACS Medicinal Chemistry Letters. 12(7). 1077–1085. 9 indexed citations
6.
Stachulski, Andrew V., Rajith K. R. Rajoli, Ghaith Aljayyoussi, et al.. (2020). Therapeutic Potential of Nitazoxanide: An Appropriate Choice for Repurposing versus SARS-CoV-2?. ACS Infectious Diseases. 7(6). 1317–1331. 38 indexed citations
7.
Nixon, Gemma L., Laura McEntee, Adam Johnson, et al.. (2018). Repurposing and Reformulation of the Antiparasitic Agent Flubendazole for Treatment of Cryptococcal Meningoencephalitis, a Neglected Fungal Disease. Antimicrobial Agents and Chemotherapy. 62(4). 36 indexed citations
8.
Hong, W. David, Suet C. Leung, Kangsa Amporndanai, et al.. (2018). Potent Antimalarial 2-Pyrazolyl Quinolone bc1 (Qi) Inhibitors with Improved Drug-like Properties. ACS Medicinal Chemistry Letters. 9(12). 1205–1210. 27 indexed citations
9.
Johnston, Kelly L., Darren A. N. Cook, Neil G. Berry, et al.. (2017). Identification and prioritization of novel anti- Wolbachia chemotypes from screening a 10,000-compound diversity library. Science Advances. 3(9). eaao1551–eaao1551. 16 indexed citations
10.
Nixon, Gemma L., Matthew Schnaderbeck, Christopher Riley, et al.. (2016). Optimisation of the synthesis of second generation 1,2,4,5 tetraoxane antimalarials. Tetrahedron. 72(40). 6118–6126. 16 indexed citations
11.
Fernández‐Álvaro, Elena, W. David Hong, Gemma L. Nixon, Paul M. O’Neill, & Félix Calderón. (2016). Antimalarial Chemotherapy: Natural Product Inspired Development of Preclinical and Clinical Candidates with Diverse Mechanisms of Action. Journal of Medicinal Chemistry. 59(12). 5587–5603. 53 indexed citations
12.
O’Neil, Ian A., Gemma L. Nixon, H. L. Billington, S. Barret Kalindjian, & Alexander Steiner. (2015). Tripodal Tris-N-oxides: Synthesis and Hydrogen Bonding Capabilities. Synlett. 27(1). 141–145. 2 indexed citations
13.
Nixon, Gemma L., Darren Moss, Alison E. Shone, et al.. (2013). Antimalarial pharmacology and therapeutics of atovaquone. Journal of Antimicrobial Chemotherapy. 68(5). 977–985. 149 indexed citations
14.
Nixon, Gemma L., Chandrakala Pidathala, Alison E. Shone, et al.. (2013). Targeting the Mitochondrial Electron Transport Chain ofPlasmodium Falciparum:New Strategies Towards the Development of Improved Antimalarials for the Elimination Era. Future Medicinal Chemistry. 5(13). 1573–1591. 53 indexed citations
15.
Fisher, Nicholas, Alison Mbekeani, Alison E. Shone, et al.. (2010). A novel drug for uncomplicated malaria: Targeted high throughput screening (HTS) against the type II NADH:ubiquinone oxidoreductase (PfNDH2) of Plasmodium falciparum. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1797. 80–80. 1 indexed citations
16.
Amewu, Richard K., Peter Gibbons, Andrew V. Stachulski, et al.. (2010). Synthesis, in vitro and in vivo antimalarial assessment of sulfide, sulfone and vinyl amide-substituted 1,2,4-trioxanes prepared via thiol-olefin co-oxygenation (TOCO) of allylic alcohols. Organic & Biomolecular Chemistry. 8(9). 2068–2068. 13 indexed citations
17.
O’Neill, Paul M., Richard K. Amewu, Gemma L. Nixon, et al.. (2010). Identification of a 1,2,4,5‐Tetraoxane Antimalarial Drug‐Development Candidate (RKA 182) with Superior Properties to the Semisynthetic Artemisinins. Angewandte Chemie International Edition. 49(33). 5693–5697. 107 indexed citations
18.
Ward, Stephen A., Nicholas Fisher, Alison Mbekeani, et al.. (2010). A novel drug for uncomplicated malaria: targeted high throughput screening (HTS) against the type II NADH:ubiquinone oxidoreductase (PfNdh2) of Plasmodium falciparum. Malaria Journal. 9(S2). 19 indexed citations
19.
O’Neill, Paul M., Richard K. Amewu, Gemma L. Nixon, et al.. (2010). Identification of a 1,2,4,5‐Tetraoxane Antimalarial Drug‐Development Candidate (RKA 182) with Superior Properties to the Semisynthetic Artemisinins. Angewandte Chemie. 122(33). 5829–5833. 21 indexed citations
20.
Gibbons, Peter, Nuna Araújo, Victoria Barton, et al.. (2010). Endoperoxide Carbonyl Falcipain 2/3 Inhibitor Hybrids: Toward Combination Chemotherapy of Malaria through a Single Chemical Entity. Journal of Medicinal Chemistry. 53(22). 8202–8206. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026